Table 5.
The rate of decrease in ulcer size (ulcers at least 400 mm2)
| Week 4 | Week 8 | |
|---|---|---|
| mean ± SD (95% CI) | ||
| 2-sample t test (ns) | ||
| H2RA | 89.3 ± 10.7% | 99.7 ± 1.0% |
| (n = 17) | (84.2–94.4) | (99.2–100) |
| PPI | 85.6 ± 25.2% | 99.5 ± 1.4% |
| (n = 20) | (74.5–96.6) | (98.9–100) |
The mean size of 17 ulcers exceeding 400 mm2 was 804.8 ± 496.8 mm2 in the H2RA group and the rate of decrease in size was 89.3 ± 10.7% at Week 4 and 99.7 ± 1.0% at Week 8. The mean size of 20 large ulcers was 896.5 ± 533.4 mm2 in the PPI group and the rate of decrease in size was 85.6 ± 25.2% at Week 4 and 99.5 ± 1.4% at Week 8. There were no significant differences between the two groups. H2RA, H2 receptor antagonist; PPI, proton pump inhibitor.